Clinical trial · Interventional
Sound Acupuncture in Painful Chemotherapy-Related Neuropathies
Effectiveness of Sound Acupuncture in Painful Chemotherapy-Related Neuropathies: A Non-Invasive Alternative to Acupuncture? Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The objective of this clinical trial is to evaluate the efficacy of sound acupuncture in combination with traditional medical therapy in the treatment of chemotherapy-induced peripheral neuropathies. Sound acupuncture is a non-invasive technique that involves stimulating energy points, used in acupuncture, with the help of specific tuning forks and the frequencies they emit. The energy points are those used in Chinese medicine and, more specifically, in acupuncture. The aim is to restore the recipient's complex bioenergetic system to an optimal state of well-being and balance Participants: 20 patients will receive only the best medical therapy; 20 patients will receive BMT and sound acupuncture treatment
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Neuropathic Pain in Cancer | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Sound acupuncture | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Sound acupuncture
- description
- Best medical therapy + Sound Acupuncture
- interventionNames
- Other: Sound acupuncture
- type
- NO_INTERVENTION
- label
- BMT
- description
- Best medical therapy
Primary outcomes (1)
- measure
- Pain reduction
- timeFrame
- 1 year
- description
- At least a 30% reduction from baseline on the NPS scale for neuropathic pain
Secondary outcomes (2)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 30 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * Age 30-80 years * Clinical and electrophysiological diagnosis of chemotherapy-induced neuropathy * Patients being treated with Best Medical Therapy for neuropathic pain * Written informed consent Exclusion Criteria: * Women who are pregnant or breastfeeding * Patients with intellectual disabilities or cognitive impairment that impair their ability to comply with the consent process * Pacemaker users
References
Publications (0)
Data not yet available